OncoTherapy Science(DE:30O)
€0.06-0.01 (-9.09%)
DE:30O
OncoTherapy Science earnings date
€0.06
At close:-0.01 (-9.09%)
OncoTherapy Science (30O) Q4 2022 Earnings Report
0 Followers
DE:30O Q4 2022 EPS Results
- Actual EPS
- -EUR 0.01
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.01
DE:30O Q4 2022 Revenue Results
- Actual Revenue
- EUR 4.61M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +374.84%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 05/06/2022
- Time
- TBA
- Conference Call
- Friday, May 6, 2022
DE:30O Upcoming Earnings
OncoTherapy Science's next earnings date is estimated for January 29, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:30O Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jan 29, 2027 | 2026 (Q3) | ―- | -0.01 | ― | ― |
| Nov 06, 2026 | 2026 (Q2) | ―-0.00 | 0 | 7.89% (+0.00) | |
| Aug 07, 2026 | 2026 (Q1) | ―-0.00 | -0.01 | 36.28% (+0.00) | |
| Feb 06, 2026 | 2025 (Q3) | ―-0.00 | 0 | -5.00% (-0.00) | |
| Feb 07, 2025 | 2024 (Q3) | ―-0.00 | -0.01 | 52.38% (+0.00) | |
| Aug 02, 2024 | 2025 (Q1) | ―-0.01 | -0.01 | 34.67% (+0.00) | |
| Aug 04, 2023 | 2024 (Q1) | ―- | ― | ― | |
| May 12, 2023 | 2023 (Q4) | ―- | ― | ― | |
| Feb 03, 2023 | 2023 (Q3) | ―- | ― | ― | |
| Aug 05, 2022 | 2023 (Q1) | ―-0.01 | -0.02 | 52.00% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

